Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Jeong Min Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0561-8777; OpenAlex author ID A5100708513. Sources: OpenAlex.

Their work

Papers
14 (first author 6, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
47
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: 3 papers · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 14

  1. Deep learning-based combined noise reduction and contrast enhancement for post-neoadjuvant pancreatic cancer CT: does improved image quality translate to bette… Last author DOI 10.1007/s00261-025-05271-6↗
  2. Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer. Co-author DOI 10.1002/jcsm.13437↗
  3. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study. Last author DOI 10.1007/s00330-023-09584-2↗
  4. Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET/MRI and CA 19-9. First author DOI 10.1186/s40644-023-00565-8↗
  5. Pancreas CT assessment for pancreatic ductal adenocarcinoma resectability: effect of tube voltage and slice thickness on image quality and diagnostic performan… Co-author DOI 10.1186/s40644-023-00637-9↗
  6. Accelerated Pancreatobiliary MRI for Pancreatic Cancer Surveillance in Patients With Pancreatic Cystic Neoplasms. Last author DOI 10.1002/jmri.28189↗
  7. How to approach pancreatic cancer after neoadjuvant treatment: assessment of resectability using multidetector CT and tumor markers. First author DOI 10.1007/s00330-021-08108-0↗
  8. Preoperative CT Classification of the Resectability of Pancreatic Cancer: Interobserver Agreement. First author DOI 10.1148/radiol.2019190422↗
  9. Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospect… Co-author DOI 10.1097/sla.0000000000002705↗
  10. Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy. First author DOI 10.2214/ajr.17.18310↗
  11. Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study. First author DOI 10.1148/radiol.2016152798↗
  12. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from… Co-author DOI 10.1007/s00330-015-3941-7↗
  13. Diagnostic performance of MDCT for predicting important prognostic factors in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318287c604↗
  14. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. First author DOI 10.1002/jmri.23609↗

Closest collaborators

The 25 strongest of 47 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jeong Hee Yoon · 5 shared papers, 2022–2026 · strength 1.05
  2. Sun Kyung Jeon · 4 shared papers, 2022–2026 · strength 0.86
  3. Ijin Joo · 7 shared papers, 2012–2024 · strength 0.86
  4. Jin‐Young Jang · 6 shared papers, 2017–2023 · strength 0.72
  5. Sang Hyub Lee · 3 shared papers, 2022–2024 · strength 0.58
  6. Dong Ho Lee · 5 shared papers, 2017–2023 · strength 0.58
  7. Eun Sun Lee · 5 shared papers, 2017–2022 · strength 0.54
  8. Mi Hye Yu · 3 shared papers, 2022–2023 · strength 0.53
  9. Jeongin Yoo · 2 shared papers, 2023–2026 · strength 0.51
  10. Hyo‐Jin Kang · 2 shared papers, 2019–2026 · strength 0.41
  11. Seung Soo Lee · 2 shared papers, 2023 · strength 0.34
  12. Seok Jin Hong · 1 shared paper, 2026 · strength 0.32
  13. Liang Zhu · 1 shared paper, 2026 · strength 0.32
  14. Woo Hyun Paik · 1 shared paper, 2024 · strength 0.24
  15. Min Woo Lee · 1 shared paper, 2024 · strength 0.24
  16. Sang Min Lee · 2 shared papers, 2019–2022 · strength 0.24
  17. Sun‐Whe Kim · 3 shared papers, 2017–2018 · strength 0.20
  18. Sae‐Jin Park · 1 shared paper, 2023 · strength 0.18
  19. Su Joa Ahn · 2 shared papers, 2018–2019 · strength 0.17
  20. Seungmin Bang · 1 shared paper, 2023 · strength 0.17
  21. Song Cheol Kim · 1 shared paper, 2023 · strength 0.17
  22. Sang Hyup Lee · 1 shared paper, 2022 · strength 0.16
  23. In Rae Cho · 1 shared paper, 2022 · strength 0.15
  24. Jae Seok Bae · 1 shared paper, 2022 · strength 0.15
  25. Ji Kon Ryu · 2 shared papers, 2017–2018 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.